• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Oncology Platform

Illumina and Syapse Partner on Biomarker Testing Research Across Oncology Practices

by Jasmine Pennic 01/05/2022 Leave a Comment

Illumina and Syapse Partner on Biomarker Testing Research Across Oncology Practices

What You Should Know: - Syapse, a real-world evidence company that informs cancer care, announced a partnership with Illumina aimed at assessing the real-world uptake and actionability of comprehensive genomic profiling in the community oncology health system setting. - Together, the two companies will work to better understand biomarker testing patterns among clinicians, which have become foundational in identifying treatment options for cancer patients. The insights gleaned from this
Read More

Bayhealth Taps Syapse’s Real-World Data Platform to Optimize Oncology Data

by Fred Pennic 12/15/2021 Leave a Comment

Bayhealth Taps Syapse’s Real-World Data Platform to Optimize Oncology Data

What You Should Know: - Syapse, a real-world evidence company that informs cancer care, announced a partnership with Bayhealth – central and southern Delaware’s largest healthcare system. - Bayhealth will leverage Syapse’ multi-source real-world data platform to bring the latest in cancer diagnostics and treatments to Delaware patients, so that they can receive evidence-based care and match to potentially life-saving clinical trial opportunities. Bringing Data-Driven Approach to
Read More

NeoGenomics Acquires Precision Oncology Platform Trapelo Health for $65M

by Fred Pennic 03/24/2021 Leave a Comment

NeoGenomics Acquires Precision Oncology Platform Trapelo Health for $65M

What You Should Know: - NeoGenomics, Inc., a provider of cancer-focused genetic testing services and global oncology contract research services announced it has reached an agreement to acquire precision oncology platform Trapelo Health for $65M. The agreement purchase price of $65 million, consists of $35 million in cash on hand and $30 million in NeoGenomics common stock and is expected to close in April 2021. - Trapelo Health offers a first-of-its-kind, interoperable, decision-support
Read More

Syapse Lands $68M to Expand Global Precision Oncology Data Sharing Network

by Fred Pennic 02/02/2021 Leave a Comment

FDA, Syapse Expand Research to Generate Real-World Data Related to COVID-19 and Cancer

What You Should Know: - Syapse raises 68M in equity investment  led by Ally Bridge Group (ABG), with Northpond Ventures to expand delivery of real-world evidence  through Syapse’s Learning Health Network. - The Syapse Learning Health Network is a global precision oncology data sharing network, improving cancer care across communities by using real-world data to support clinical decisions. Syapse, a San Francisco, CA-based real-world evidence company accelerating the delivery
Read More

COTA Lands $34M to Drive Innovation in Oncology Using Real-World Data

by Fred Pennic 11/18/2020 Leave a Comment

COTA Lands $34M to Drive Innovation in Oncology Using Real-World Data

What You Should Know: - COTA, Inc., a healthcare technology company that uses real-world data to bring clarity to cancer care, has secured $34M in funding. - Access to over one million patient data records and additional funding support enhanced real-world data and analytics services in oncology. COTA, Inc., a Boston, MA-based healthcare technology company that uses real-world data to bring clarity to cancer care, today announced it has raised $34 million in Series D funding led by
Read More

M&A: RxVantage Acquires onPoint Oncology to Expand Offering to Oncology Practices

by Jasmine Pennic 11/10/2020 Leave a Comment

M&A: RxVantage Acquires onPoint Oncology to Expand Offering to Oncology Practices

What You Should Know: - RxVantage has acquired onPoint Oncology to provide cancer care teams with on-demand access to educational resources, reimbursement data, and analytics. - The acquisition of onPoint Oncology builds on RxVantage’s rapidly expanding digital offerings for providers. In April, RxVantage launched Virtual Meetings to help providers reestablish access to life science experts amidst the disruptions caused by COVID-19. RxVantage, the leading digital
Read More

CancerIQ Raises $5M to Expand Genetic Cancer Risk Assessment Platform

by Fred Pennic 08/14/2020 Leave a Comment

CancerIQ Raises $5M to Expand Genetic Cancer Risk Assessment Platform

What You Should Know: - CancerIQ raises $5M in Series A funding led by HealthXVentures to accelerate the growth of its genetic cancer risk assessment platform to identify and manage patients at high risk of cancer. - CancerIQ’s technology enables hospitals to use genomics to personalize the prevention and early detection of cancer. - Two new hires recently joined CancerIQ’s newly formed Integrated Products team from Epic, with the goal of advancing CancerIQ’s integration with leading
Read More

Oncology Analytics Lands $28M to Expand Oncology Capabilities

by Fred Pennic 05/26/2020 Leave a Comment

Oncology Analytics Lands $28M to Expand Oncology Capabilities

What You Should Know: - Oncology Analytics raises $28M in Series C funding led by Baird Capital to expand its oncology-focused capabilities, accelerate real-world data and analytics solutions for health plans, and increase the market share of its technology-enabled utilization management solution.  - Oncology Analytics' prior authorization platform is used by physicians to support 5 million health plan members in the US and Puerto Rico and covers the full spectrum of therapeutics, across
Read More

OSF HealthCare Integrates CancerIQ with Epic EHR to Expand Genetics to Primary Care

by Fred Pennic 09/18/2019 Leave a Comment

OSF Healthcare In Talks To Merge With Little Company of Mary Hospital, Expected to Close Early 2020

 - OSF HealthCare integrates CancerIQ’s genetic cancer risk assessment program with Epic’s EHR platform to reduce cancer disparities and deaths. - OSF has screened nearly 70k patients using CancerIQ’s platform and will be deployed to primary care practices throughout the system. OSF HealthCare, an integrated healthcare network with locations in Illinois and Michigan, has integrated CancerIQ’s genetic cancer risk assessment program with Epic’s EHR platform as part of a system-wide population
Read More

Navigating Cancer Lands $26M to Expand Oncology Patient Relationship Management Platform

by Fred Pennic 09/17/2019 Leave a Comment

Navigating Cancer Lands $26M to Expand Oncology Patient Relationship Management Platform

- Navigating Cancer raises $26M in Series D funding in an over-subscribed round (TTCP) for its comprehensive oncology patient relationship management solution. - Navigating Cancer’s PRM platform helps providers manage patient interactions, improve the patient experience, and deliver value-based care more effectively – increasing the flow of communications between in-office visits, which, in turn, boosts patient engagement in their own care. - Funding will enable NC to accelerate innovation of
Read More

  • Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |